Estrella Immunopharma Inc...

NASDAQ: ESLA · Real-Time Price · USD
0.91
0.05 (5.76%)
At close: Aug 15, 2025, 3:59 PM
0.89
-1.70%
After-hours: Aug 15, 2025, 04:12 PM EDT

Estrella Immunopharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Feb 28, 2021
Net Income
-12.08M -10.48M -8.85M -8.82M -7.31M -3.44M -3.03M -4.77M -3.24M -4.24M -4.34M -1.72M -1.49M -415.19K -247.72K -111.92K -4.37K -819
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a 5.49K -23.98K -23.98K -23.98K -29.47K n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
318.19K 159.09K n/a n/a 1.19M 1.19M 1.3M 1.4M 204.8K 238.93K 197.52K 95.12K 95.12K 60.98K n/a n/a n/a n/a
Other Working Capital
7.32M 6.01M 847.78K 140.03K -618.09K -4.3M -697.47K 241.79K -218.37K -182.51K -112.81K -222.95K -66.81K -79.72K -64.51K 92.13K n/a n/a
Other Non-Cash Items
432.26K 432.26K 509.33K 9.34M 10.53M 10.41M 10.23M 979.04K -515.48K -565.79K -466.69K -476.53K -172.74K -10.62K -3.93K -3.07K -2.5K n/a
Deferred Income Tax
n/a n/a n/a n/a n/a 598.00 -21.1K 8.37K 8.37K 7.77K 29.47K n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
7.33M 6.02M 775.7K -9.19M -9.95M -13.63M -9.95M 2.83M 2.46M 2.6M 2.67M -19.45K 36.63K -76.72K -64.51K 92.13K n/a n/a
Operating Cash Flow
-3.99M -3.87M -7.64M -18.01M -16.07M -15.99M -12.03M -871.77K -1.11M -1.82M -1.66M -1.84M -1.34M -422.65K -316.16K -22.86K -6.87K -819
Capital Expenditures
-4 -1 -1 3.00 3.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a -136.53K -273.07K -273.07K -273.07K -136.53K n/a n/a -42M -45.19M -45.19M -45.19M -3.19M n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a 157.96K 372.27K 36.54M 36.54M 36.38M 36.17M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 5.07M 4.96M 4.96M 4.96M -112.3K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a 5.07M 4.96M 4.98M 5.06M 36.16M 36.27M 36.25M 36.17M n/a -42M -45.19M -45.19M -45.19M -3.19M n/a
Debt Repayment
n/a -10M -10M -10.3M n/a 10.2M 10.38M 10.68M 383.07K 186.53K n/a n/a 120K -100K -100K -100K -220K n/a
Common Stock Repurchased
-122.94K -514.29K -568.92K -5.58M -5.43M -5.16M -5.07M -36.11M -36.11M -36.11M -36.11M n/a -25K -25K -25K -25K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-190.47K 9.58M 9.58M 8.05M -1.07M -10.8M -10.8M -9.22M 548.6K 563.6K 670.91K 620.91K -576.59K -699.01K -761K -761K -62.1K 45.32K
Financial Cash Flow
1.15M -434.8K -489.43K -7.4M 12.79M 13.26M 13.53M -15.63M -35.18M -30.36M -30.44M 5.62M 47.9M 46.04M 45.98M 45.98M 3.21M 45.32K
Net Cash Flow
-2.85M -4.31M -8.13M -20.34M 1.69M 2.25M 6.56M 19.54M -128.84K 3.63M 3.49M 3.3M 4.08M 277.22K 478.87K 772.17K 11.02K 44.5K
Free Cash Flow
-3.99M -3.87M -7.64M -18.01M -16.07M -15.99M -12.03M -871.77K -1.11M -1.82M -1.66M -1.84M -1.34M -422.65K -316.16K -22.86K -6.87K -819